• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number GSX0025A
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Chest Pain (1776); Pericardial Effusion (3271)
Event Date 06/15/2016
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.(b)(4).
 
Event Description
It was reported the physician selected a 30mm gore cardioform septal occluder to close a patent foramen ovale.The physician experienced difficulty deploying the left atrial disc, which appeared unable to form properly due to interference with surrounding anatomical structures.As a result, the physician formed the left disc deeper in the left atrium and the device was implanted with good result.Following the procedure, the patient experienced chest pain.The day after the procedure a pericardial effusion was noted and therapeutic pericardiocentesis was performed.
 
Manufacturer Narrative
Describe event or problem - this section has been corrected to reflect the correct size of device selected for the procedure.The initial medwatch report event description said the physician selected a 30mm gore cardioform septal occluder; however, the physician actually selected a 25mm gore cardioform septal occluder.Only the device size noted in the event description was incorrect.The device information throughout the initial report is correct.
 
Event Description
It was reported the physician selected a 25mm gore cardioform septal occluder to close a patent foramen ovale.The physician experienced difficulty deploying the left atrial disc, which appeared unable to form properly due to interference with surrounding anatomical structures.As a result, the physician formed the left disc deeper in the left atrium and the device was implanted with good result.Following the procedure, the patient experienced chest pain.The day after the procedure, a pericardial effusion was noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5785117
MDR Text Key49277928
Report Number2017233-2016-00625
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/12/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/18/2018
Device Catalogue NumberGSX0025A
Device Lot Number14983148
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/12/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/12/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-